Clarus Group Inc. trimmed its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 39.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,049 shares of the company’s stock after selling 4,683 shares during the quarter. Johnson & Johnson comprises […]